| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Renate Thienel, Bianca Voss, Thilo Kellermann, Martina Reske, Sarah Halfter, Abigail J Sheldrick, Katrin Radenbach, Ute Habel, Nadim Jon Shah, Ulrich Schall, Tilo Kirche. Nicotinic antagonist effects on functional attention networks. The international journal of neuropsychopharmacology. vol 12. issue 10. 2010-06-29. PMID:19737441. |
the latter nicotine antagonist effect may be mediated via cholinergic modulation of dopamine neurotransmission in mesolimbic pathways. |
2010-06-29 |
2023-08-12 |
human |
| Greg L Clar. Mood disorders in patients with COPD: overview of current research and future needs. Expert review of neurotherapeutics. vol 3. issue 2. 2010-06-28. PMID:19810837. |
in this review, the theorectical relationship that exists between dopamine, serotonin and nicotine and how the biochemical nicotine dependence issues (with regard to mood) may actually be a key element in the understanding and treatment of depression later in the life of the development of chronic lung disease and depression, are discussed. |
2010-06-28 |
2023-08-12 |
Not clear |
| Andrew M Smith, Marharyta Pivavarchyk, Thomas E Wooters, Zhenfa Zhang, Guangrong Zheng, J Michael McIntosh, Peter A Crooks, Michael T Bardo, Linda P Dwoski. Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release. Biochemical pharmacology. vol 80. issue 3. 2010-06-22. PMID:20346923. |
repeated nicotine administration robustly increases bpiddb inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release. |
2010-06-22 |
2023-08-12 |
rat |
| Se Hee Kim, Doug Hyun Han, So Youn Joo, Kyung Joon Mi. The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia. Human psychopharmacology. vol 25. issue 2. 2010-06-14. PMID:20033907. |
the effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia. |
2010-06-14 |
2023-08-12 |
Not clear |
| Rafael Maldonado, Fernando Berrender. Endogenous cannabinoid and opioid systems and their role in nicotine addiction. Current drug targets. vol 11. issue 4. 2010-06-10. PMID:20017727. |
for a long time, dopamine has been considered one of the most important neurotransmitters in mediating the rewarding effects of nicotine. |
2010-06-10 |
2023-08-12 |
Not clear |
| Lei Phillip Wang, Fei Li, Xiaoming Shen, Joe Z Tsie. Conditional knockout of NMDA receptors in dopamine neurons prevents nicotine-conditioned place preference. PloS one. vol 5. issue 1. 2010-05-20. PMID:20062537. |
heterogeneity of cell populations in the region has made it difficult for pharmacology-based analyses to precisely assess the functional significance of glutamatergic inputs to dopamine neurons in nicotine addiction. |
2010-05-20 |
2023-08-12 |
mouse |
| Lei Phillip Wang, Fei Li, Xiaoming Shen, Joe Z Tsie. Conditional knockout of NMDA receptors in dopamine neurons prevents nicotine-conditioned place preference. PloS one. vol 5. issue 1. 2010-05-20. PMID:20062537. |
therefore, this selective effect on addictive drug-induced reinforcement behavior suggests that nmda receptors in the dopamine neurons are critical for the development of nicotine addiction. |
2010-05-20 |
2023-08-12 |
mouse |
| Gordana Nedic, Matea Nikolac, Fran Borovecki, Sanja Hajnsek, Dorotea Muck-Seler, Nela Piva. Association study of a functional catechol-O-methyltransferase polymorphism and smoking in healthy Caucasian subjects. Neuroscience letters. vol 473. issue 3. 2010-05-17. PMID:20188797. |
these results suggest that carriers of the high activity comt variant are more prone to develop a higher level of nicotine dependence, or that they release more dopamine than carriers of met/met or met/val genotypes. |
2010-05-17 |
2023-08-12 |
human |
| Cecilia Gotti, Stefania Guiducci, Vincenzo Tedesco, Silvia Corbioli, Lara Zanetti, Milena Moretti, Alessio Zanardi, Roberto Rimondini, Manolo Mugnaini, Francesco Clementi, Christian Chiamulera, Michele Zol. Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 30. issue 15. 2010-05-14. PMID:20392953. |
nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. |
2010-05-14 |
2023-08-12 |
rat |
| V Knott, A Millar, D Fisher, P Alber. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism. Neuroscience. vol 166. issue 1. 2010-05-04. PMID:19961902. |
effects of nicotine on the amplitude and gating of the auditory p50 and its influence by dopamine d2 receptor gene polymorphism. |
2010-05-04 |
2023-08-12 |
human |
| V Knott, A Millar, D Fisher, P Alber. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism. Neuroscience. vol 166. issue 1. 2010-05-04. PMID:19961902. |
in a randomized, double-blind, placebo-controlled design with 24 non-smokers, this study examined the influence of taqia dopamine d2 receptor gene polymorphisms on p50 and its inhibition during nicotine gum (6 mg) administration. |
2010-05-04 |
2023-08-12 |
human |
| V Knott, A Millar, D Fisher, P Alber. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism. Neuroscience. vol 166. issue 1. 2010-05-04. PMID:19961902. |
these findings suggest that nicotine exerts mixed gating properties in healthy nicotine naive volunteers and that dopamine functions to alter both p50 and its gating as well as their response to acute nicotine agonist treatment. |
2010-05-04 |
2023-08-12 |
human |
| Taryn E Grieder, Laurie H Sellings, Hector Vargas-Perez, Ryan Ting-A-Kee, Eric C Siu, Rachel F Tyndale, Derek van der Koo. Dopaminergic signaling mediates the motivational response underlying the opponent process to chronic but not acute nicotine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 35. issue 4. 2010-04-28. PMID:20032966. |
the mesolimbic dopamine (da) system is implicated in the processing of the positive reinforcing effect of all drugs of abuse, including nicotine. |
2010-04-28 |
2023-08-12 |
mouse |
| Donnie Eddins, Daniel Cerutti, Paul Williams, Elwood Linney, Edward D Levi. Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. Neurotoxicology and teratology. vol 32. issue 1. 2010-04-22. PMID:19268529. |
zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. |
2010-04-22 |
2023-08-12 |
rat |
| Maryka Quik, Carla Campos, Neeraja Parameswaran, J William Langston, J Michael McIntosh, Michael Yeluashvil. Chronic nicotine treatment increases nAChRs and microglial expression in monkey substantia nigra after nigrostriatal damage. Journal of molecular neuroscience : MN. vol 40. issue 1-2. 2010-04-21. PMID:19685015. |
nicotine treatment did not affect the dopamine transporter or the number of tyrosine hydroxylase positive cells in the substantia nigra of lesioned monkeys. |
2010-04-21 |
2023-08-12 |
monkey |
| Yu Dong, Tianxiang Zhang, Wei Li, William M Doyon, William Doyon, John A Dan. Route of nicotine administration influences in vivo dopamine neuron activity: habituation, needle injection, and cannula infusion. Journal of molecular neuroscience : MN. vol 40. issue 1-2. 2010-04-21. PMID:19714495. |
route of nicotine administration influences in vivo dopamine neuron activity: habituation, needle injection, and cannula infusion. |
2010-04-21 |
2023-08-12 |
rat |
| Yu Dong, Tianxiang Zhang, Wei Li, William M Doyon, William Doyon, John A Dan. Route of nicotine administration influences in vivo dopamine neuron activity: habituation, needle injection, and cannula infusion. Journal of molecular neuroscience : MN. vol 40. issue 1-2. 2010-04-21. PMID:19714495. |
mesolimbic dopamine (da) systems play a critical role in tobacco addiction driven by nicotine. |
2010-04-21 |
2023-08-12 |
rat |
| Christelle Reperant, Stéphanie Pons, Eric Dufour, Hans Rollema, Alain M Gardier, Uwe Masko. Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area. Neuropharmacology. vol 58. issue 2. 2010-04-13. PMID:19887076. |
we studied the effects of 1 mg/kg doses of nicotine and the alpha4beta2* nicotinic acetylcholine receptor (nachr) partial agonist, varenicline, on extracellular dopamine (da) levels in the nucleus accumbens (nuacc) of lentivirally vectorized male mice. |
2010-04-13 |
2023-08-12 |
mouse |
| K Ohyama, C Sogawa, N Sogawa, K Morita, T Dohi, S Kitayam. Nicotine stimulates transcriptional activity of the human dopamine transporter gene. Neuroscience letters. vol 471. issue 1. 2010-04-05. PMID:20074615. |
nicotine stimulates transcriptional activity of the human dopamine transporter gene. |
2010-04-05 |
2023-08-12 |
human |
| K Ohyama, C Sogawa, N Sogawa, K Morita, T Dohi, S Kitayam. Nicotine stimulates transcriptional activity of the human dopamine transporter gene. Neuroscience letters. vol 471. issue 1. 2010-04-05. PMID:20074615. |
nicotine modulates dopaminergic activity in the central nervous system by acting on the reuptake system, including the dopamine transporter (dat), although precisely remains unclear. |
2010-04-05 |
2023-08-12 |
human |